Amedeo Smart

Free Medical Literature Service

 

Amedeo

Chronic Renal Failure
  Free Subscription

Articles published in
N Engl J Med
    April 2024
  1. VAZQUEZ MA, Oliver G, Amarasingham R, Sundaram V, et al
    Pragmatic Trial of Hospitalization Rate in Chronic Kidney Disease.
    N Engl J Med. 2024;390:1196-1206.
    >> Share

    March 2024
  2. XU BP, Wang XT
    Green Dialysis Effluent and Plasma.
    N Engl J Med. 2024;390:e27.
    >> Share

    January 2024
  3. CHANG LL, Rhee CM, Kalantar-Zadeh K, Woodrow G, et al
    Dietary Protein Restriction in Patients with Chronic Kidney Disease.
    N Engl J Med. 2024;390:86-89.
    >> Share

    November 2023
  4. BLANKESTIJN PJ, Bots ML
    Effect of Hemodiafiltration or Hemodialysis on Mortality in Kidney Failure. Reply.
    N Engl J Med. 2023;389:e42.
    >> Share

  5. PICCOLI GB, Torreggiani M, Fessi H
    Effect of Hemodiafiltration or Hemodialysis on Mortality in Kidney Failure.
    N Engl J Med. 2023;389:e42.
    >> Share

  6. LABRIOLA L, Fernandes G, Jadoul M
    Effect of Hemodiafiltration or Hemodialysis on Mortality in Kidney Failure.
    N Engl J Med. 2023;389:e42.
    >> Share

  7. ARGILES A, Ficheux A, Duranton F
    Effect of Hemodiafiltration or Hemodialysis on Mortality in Kidney Failure.
    N Engl J Med. 2023;389:e42.
    >> Share

    August 2023
  8. GOLPER TA
    Improving Dialysis Techniques for Patients?
    N Engl J Med. 2023;389:762-763.
    >> Share

    June 2023
  9. EGBUNA O, Chertow GM
    Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants. Reply.
    N Engl J Med. 2023;388:2491.
    >> Share

  10. SOLER MJ, Glassock RJ, Fervenza FC
    Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants.
    N Engl J Med. 2023;388:2490.
    >> Share

  11. BLANKESTIJN PJ, Vernooij RWM, Hockham C, Strippoli GFM, et al
    Effect of Hemodiafiltration or Hemodialysis on Mortality in Kidney Failure.
    N Engl J Med. 2023 Jun 16. doi: 10.1056/NEJMoa2304820.
    >> Share

  12. HERRINGTON WG, Baigent C, Haynes R
    Empagliflozin in Patients with Chronic Kidney Disease. Reply.
    N Engl J Med. 2023;388:2301-2302.
    >> Share

  13. SINGH AK, Farag YMK, Agarwal R
    Empagliflozin in Patients with Chronic Kidney Disease.
    N Engl J Med. 2023;388:2301.
    >> Share

  14. FUESSL L, Wehrmann F, Schonermarck U
    Empagliflozin in Patients with Chronic Kidney Disease.
    N Engl J Med. 2023;388:2300-2301.
    >> Share

  15. NEUEN BL, Fletcher RA, Heerspink HJL
    Empagliflozin in Patients with Chronic Kidney Disease.
    N Engl J Med. 2023;388:2300.
    >> Share

    February 2023
  16. HUTH L, Schafer L, Almanzar G, Lupoli G, et al
    Immunologic Effect of Bivalent mRNA Booster in Patients Undergoing Hemodialysis.
    N Engl J Med. 2023 Feb 15. doi: 10.1056/NEJMc2216309.
    >> Share

    January 2023
  17. AUGUST P
    Chronic Kidney Disease - Another Step Forward.
    N Engl J Med. 2023;388:179-180.
    >> Share

    December 2022
  18. MC CAUSLAND FR, Singh AK, Claggett BL, Carroll K, et al
    Daprodustat and On-Treatment Cardiovascular Events in Chronic Kidney Disease. Reply.
    N Engl J Med. 2022;387:2482-2485.
    >> Share

  19. HUANG C, He Y, Li Y
    Daprodustat and On-Treatment Cardiovascular Events in Chronic Kidney Disease.
    N Engl J Med. 2022;387:2482.
    >> Share

  20. ROJAS-RIVERA J, Carriazo S, Ortiz A
    Daprodustat and On-Treatment Cardiovascular Events in Chronic Kidney Disease.
    N Engl J Med. 2022;387:2481-2482.
    >> Share

    November 2022
  21. HERRINGTON WG, Staplin N, Wanner C, Green JB, et al
    Empagliflozin in Patients with Chronic Kidney Disease.
    N Engl J Med. 2022 Nov 4. doi: 10.1056/NEJMoa2204233.
    >> Share

  22. BHANDARI S, Mehta S, Khwaja A, Cleland JGF, et al
    Renin-Angiotensin System Inhibition in Advanced Chronic Kidney Disease.
    N Engl J Med. 2022 Nov 3. doi: 10.1056/NEJMoa2210639.
    >> Share

    October 2022
  23. TUTTLE KR, Jones CR, Daratha KB, Koyama AK, et al
    Incidence of Chronic Kidney Disease among Adults with Diabetes, 2015-2020.
    N Engl J Med. 2022;387:1430-1431.
    >> Share

    June 2022
  24. LEVEY AS, Grams ME, Inker LA
    Uses of GFR and Albuminuria Level in Acute and Chronic Kidney Disease.
    N Engl J Med. 2022;386:2120-2128.
    >> Share

    March 2022
  25. MORELLE J, Davies S, Devuyst O
    AQP1 Promoter Variant, Water Transport, and Outcome in Peritoneal Dialysis. Reply.
    N Engl J Med. 2022;386:1098.
    >> Share

  26. MORITA H, Komuro I
    AQP1 Promoter Variant, Water Transport, and Outcome in Peritoneal Dialysis.
    N Engl J Med. 2022;386:1096-1098.
    >> Share

  27. ZHOU XJ, Xu X, Dong J
    AQP1 Promoter Variant, Water Transport, and Outcome in Peritoneal Dialysis.
    N Engl J Med. 2022;386:1096.
    >> Share

  28. XIE X, Zhang X
    Primary Hyperoxaluria.
    N Engl J Med. 2022;386:976.
    >> Share

    December 2021
  29. WHEELER DC
    Chlorthalidone in Advanced Chronic Kidney Disease - Have We Missed a Trick?
    N Engl J Med. 2021;385:2574-2575.
    >> Share

    November 2021
  30. SINGH AK, Carroll K, McMurray JJV, Solomon S, et al
    Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis.
    N Engl J Med. 2021 Nov 5. doi: 10.1056/NEJMoa2113380.
    >> Share

  31. SINGH AK, Carroll K, Perkovic V, Solomon S, et al
    Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis.
    N Engl J Med. 2021 Nov 5. doi: 10.1056/NEJMoa2113379.
    >> Share

  32. AGARWAL R, Sinha AD, Cramer AE, Balmes-Fenwick M, et al
    Chlorthalidone for Hypertension in Advanced Chronic Kidney Disease.
    N Engl J Med. 2021 Nov 5. doi: 10.1056/NEJMoa2110730.
    >> Share

  33. TEITELBAUM I
    Peritoneal Dialysis.
    N Engl J Med. 2021;385:1786-1795.
    >> Share

    October 2021
  34. MORELLE J, Marechal C, Yu Z, Debaix H, et al
    AQP1 Promoter Variant, Water Transport, and Outcomes in Peritoneal Dialysis.
    N Engl J Med. 2021;385:1570-1580.
    >> Share

  35. CHERTOW GM, Eckardt KU
    Vadadustat for Anemia in Patients with Dialysis-Dependent or Non-Dialysis-Dependent Chronic Kidney Disease. Reply.
    N Engl J Med. 2021;385:e56.
    >> Share

  36. BUNN HF
    Vadadustat for Anemia in Patients with Dialysis-Dependent or Non-Dialysis-Dependent Chronic Kidney Disease.
    N Engl J Med. 2021;385:e56.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016